Natacha Cerny

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

E. Malchiodi, S. Cazorla, T. Ebensen, 2017, npj Vaccines.

Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti-Trypanosoma cruzi Activity

M. F. Beer, E. Malchiodi, J. Padrón, 2022, Molecules.

Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine

E. Malchiodi, S. Cazorla, G. González, 2018, PLoS neglected tropical diseases.

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi

E. Malchiodi, S. Cazorla, T. Ebensen, 2020, Frontiers in Immunology.

Cytokines expression from altered motor thalamus and behavior deficits following sublethal administration of Shiga toxin 2a involve the induction of the globotriaosylceramide receptor.

E. Malchiodi, Clara Berdasco, M. D. De Marzi, 2022, Toxicon : official journal of the International Society on Toxinology.

Detection and Reinforcement of Celiac Communities on Twitter Argentina.

Gabriel Hernán Tolosa, Andrés Giordano, Santiago Banchero, 2019 .

Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.

M. Alonso, E. Malchiodi, S. Cazorla, 2017, PLoS neglected tropical diseases.

Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi

E. Malchiodi, S. Cazorla, C. Morales, 2020, Frontiers in Immunology.

Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control.

E. Malchiodi, Andrés Sánchez Alberti, N. Cerny, 2020, Biochimica et biophysica acta. Molecular basis of disease.